Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Net Income | -13.52% | 94.27% | -1,390.26% | 50.46% | 4.48% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -99.42% |
| Total Amortization of Deferred Charges | 34.68% | -- | -- | -- | 625.93% |
| Total Other Non-Cash Items | -- | -- | 2,296.99% | -46.93% | -- |
| Change in Net Operating Assets | 44.90% | -98.83% | 2,176.73% | -143.63% | -75.75% |
| Cash from Operations | 1.72% | -460.97% | 85.79% | 9.34% | -6.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 133.86% | -- | -100.00% | -14.56% | 400.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 133.86% | -- | -100.00% | -14.56% | 400.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 331.14% | -63.57% | -211.16% | -41.26% | 128.37% |